#global-innovation

#global-innovation

While China's pharma industry is close to becoming the world leader, the U.S. still holds key advantages in innovation, but the gap is shrinking.

Rest of World is a nonprofit publication rewriting the map of global tech journalism, focusing on innovation and adaptation outside the Western bubble.

New language emphasizes the importance of providing U.S. innovators with full and fair opportunities to use their IP and calls out foreign markets that fail to appropriately recognize the value of innovative medicines and medical devices.

While China's pharma industry is close to becoming the world leader, the U.S. still holds key advantages in innovation, but the gap is shrinking.

Rest of World is a nonprofit publication rewriting the map of global tech journalism, focusing on innovation and adaptation outside the Western bubble.

New language emphasizes the importance of providing U.S. innovators with full and fair opportunities to use their IP and calls out foreign markets that fail to appropriately recognize the value of innovative medicines and medical devices.